SCHEMBL9640606

SCHEMBL9640606

CCNc1cccnc1N1CCN(OS(C)(=O)=O)CC1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.48
CHIA Q9BZP6 1/20 0.41
HSD11B1 P28845 4/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
POLB P06746 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
IDO1 P14902 1/20 0.36
DRD4 P21917 1/20 0.35
HTR3E A5X5Y0 1/20 0.35
HTR3B O95264 1/20 0.35
HTR3A P46098 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9640899 0.80 PARP1 (0.52) PARP1CHIAMEN1KMT2APOLB
Hydrochloric Acid SCHEMBL9755174 0.79 PARP1 (0.51) PARP1CHIAMEN1KMT2APOLB
SCHEMBL9755187 0.78 PARP1 (0.50) PARP1CHIAMEN1KMT2APOLB
SCHEMBL9225056 0.76 PARP1 (0.49) PARP1CHIAALDH1A1IDO1
SCHEMBL9639398 0.75 PARP1 (0.48) PARP1CHIAMEN1KMT2APOLB
SCHEMBL10365748 0.75 HRH3 (0.47)
SCHEMBL3334093 0.75 EPHX2 (0.51) PARP1HTR3EHTR3BHTR3AHTR3D
SCHEMBL9639412 0.75 MAPK1 (0.52) PARP1CHIAPOLBALDH1A1IDO1
SCHEMBL9755222 0.75 PARP1 (0.52) PARP1CHIAHSD11B1MEN1KMT2A
SCHEMBL10365750 0.74 HRH3 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0496746-A1 PHARMACEUTICALLY ACTIVE AMINO-SUBSTITUTED HETEROARYL AMINES THE UPJOHN COMPANY (US) 1992-08-05 EP claimed
WO-1991006542-A1 PHARMACEUTICALLY ACTIVE AMINO-SUBSTITUTED HETEROARYL AMINES THE UPJOHN COMPANY (US) 1991-05-16 WO claimed